US FDA approves Incyte's eczema treatment for pediatric patients

Incyte(US:INCY) Reuters·2025-09-18 20:29

The U.S. Food and Drug Administration has approved Incyte's eczema treatment for children aged between 2 and 11 years, the company said on Thursday. ...